lysine has been researched along with Injuries, Radiation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berndsen, SC; Boerman, OC; de Jong, M; de Swart, J; de Visser, M; Koelewijn, S; Krenning, EP; Melis, M; Valkema, R | 1 |
| Barone, R; Bouterfa, H; Carlier, P; Chen, T; de Camps, J; Jamar, F; Krenning, EP; Kvols, LK; Labar, D; Mathieu, I; Pauwels, S; Schran, H; Smith, MC; Valkema, R; Walrand, S | 1 |
| Bernard, B; Bijster, M; de Jong, M; Forrer, F; Krenning, EP; Rolleman, EJ; Valkema, R; Vermeij, M | 1 |
1 trial(s) available for lysine and Injuries, Radiation
| Article | Year |
|---|---|
86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion.
Topics: Adult; Aged; Amino Acids; Arginine; Cohort Studies; Cross-Over Studies; Dizziness; Drug Combinations; Female; Humans; Infusions, Intravenous; Kidney; Lysine; Male; Metabolic Clearance Rate; Middle Aged; Neuroendocrine Tumors; Octreotide; Organ Specificity; Radiation Dosage; Radiation Injuries; Radiation-Protective Agents; Radiometry; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Vomiting; Yttrium Radioisotopes | 2003 |
2 other study(ies) available for lysine and Injuries, Radiation
| Article | Year |
|---|---|
Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.
Topics: Albumins; Animals; Autoradiography; Creatinine; Glomerular Filtration Rate; Kidney; Kidney Diseases; Kidney Tubules; Lysine; Male; Octreotide; Organometallic Compounds; Pentetic Acid; Proteinuria; Radiation Injuries; Radioisotope Renography; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Mertiatide; Tomography, Emission-Computed, Single-Photon | 2010 |
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.
Topics: Amifostine; Animals; Body Weight; Creatinine; Kidney; Lysine; Male; Neoplasms; Octreotide; Organometallic Compounds; Proteinuria; Radiation Injuries; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Tomography, Emission-Computed, Single-Photon | 2007 |